Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations
about
D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHDMotor coordination deficits in mice lacking RGS9Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout miceInvestigating striatal function through cell-type-specific manipulationsThe role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout miceIntranasal Chromium Induces Acute Brain and Lung Injuries in Rats: Assessment of Different Potential Hazardous Effects of Environmental and Occupational Exposure to Chromium and Introduction of a Novel Pharmacological and Toxicological Animal ModelParkin-deficient mice are not a robust model of parkinsonism.Lack of self-administration of cocaine in dopamine D1 receptor knock-out miceRole of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gatingTransient neuromotor phenotype in transgenic spastic mice expressing low levels of glycine receptor beta-subunit: an animal model of startle disease.Adenosine A2A receptor signaling and golf assembly show a specific requirement for the gamma7 subtype in the striatumDual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors.D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors.Targeting neuronal populations of the striatumA behavioral genetics approach to understanding D1 receptor involvement in phasic dopamine signaling.Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspectsHabituation and sensitization of acoustic startle: opposite influences of dopamine D1 and D2-family receptors.Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior.Distinct motor impairments of dopamine D1 and D2 receptor knockout mice revealed by three types of motor behavior.Activation of neurotensin receptor type 1 attenuates locomotor activity.Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling.Dopamine receptor loss of function is not protective of rd1 rod photoreceptors in vivo.Resveratrol attenuates oxidative stress and improves behaviour in 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice.Precision in mouse behavior genetics.Driven to be inactive? The genetics of physical activityPredictors of high ethanol consumption in RIIbeta knock-out mice: assessment of anxiety and ethanol-induced sedation.Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption.Bromocriptine increased operant responding for high fat food but decreased chow intake in both obesity-prone and resistant rats.N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effectsDopamine-dependent synaptic plasticity in striatum during in vivo developmentDistinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites.Dopamine receptor mediation of the exploratory/hyperactivity effects of modafinil.Pituitary and brain dopamine D2 receptors regulate liver gene sexual dimorphismHomer2 deletion alters dendritic spine morphology but not alcohol-associated adaptations in GluN2B-containing N-methyl-D-aspartate receptors in the nucleus accumbensLoss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex.Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptorsCoexpressed D1- and D2-like dopamine receptors antagonistically modulate acetylcholine release in Caenorhabditis elegans.Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender.Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine ReceptorsDopamine receptors and Parkinson's disease
P2860
Q24627768-F9BE3008-6B91-4E09-853B-3941FE6AA1E8Q24648527-CA6E61DC-C481-4AEE-BFA6-E89B5C202CBAQ24678512-89369487-B86B-404E-AAB3-ADF906FB49A6Q27026279-3946C257-6549-443B-A3ED-BDCB1BE9C1C9Q28348761-8C9A92D5-CB5D-4DA1-AA1F-6B77DDF76BADQ28396884-C8265579-C508-495E-BF38-0DFDE15939F1Q28504677-FA0F2D43-246C-436E-B5AE-3195B1EF55C8Q28511866-629299AF-1DE0-4EDE-AE68-6BBFB4543CDAQ28589225-9D8E1D60-2283-46A9-A351-6D0128DB0951Q28592620-9281EF6E-B691-4745-B64E-FED4CBE9C121Q30430643-2453B5FC-DEA1-4CB3-8568-08C19AA8C84DQ30450310-D41513A9-7C48-47AF-A1B2-4946B46B84AAQ30453020-F00E1535-2F00-4136-A029-5FA71F9F0176Q30474602-667951EF-C921-40C0-A68D-50BCA198D9D3Q30474975-19462819-3FB6-48F8-85BE-3D5D17C1EC2BQ30476813-449CB025-D90F-4A21-90D7-CD960C2AA7AAQ30479796-655D5CEA-B850-44B7-AD97-94A8E019CDAEQ30490216-F25ED81F-D990-4C1E-9308-BACB47001576Q30583673-506488DA-7649-4C29-9D76-D199E400D6D7Q30584554-ED3EA1EB-89FD-4972-98D6-FDA04A9D4476Q30762059-B4E7291C-115C-4EC3-B068-52AAEA33C87AQ33552905-DA8C3708-A610-46BB-8AB9-296C7002BC08Q33979340-EE4019D4-9624-4A3F-B424-C16E91116937Q34245721-6D39670E-E1F1-4143-A5D9-69457FB9469FQ34281358-751C88AB-7D08-491B-B378-6B624096B171Q34333916-1146944B-7451-447E-A5F5-150061D01FB1Q34419703-13CC4F2D-71D9-4AF5-9503-E631A12F3F60Q34476706-940E6842-0935-46B4-A0BE-E3657434831FQ34552126-EB5CB35C-A9B2-4C9E-A97F-4B21D791CBB1Q34658296-8295AE88-3BD9-49EB-BD94-322D6E1A9B0FQ34923951-9BCD17E9-258F-4F64-A220-4FAFFE1F5E67Q34988400-2E75EAFA-B71B-4253-AA79-85019878BDDDQ35088812-A9AF237B-25D0-4247-8F21-EB84A7980927Q35110328-D197E03E-6885-466C-821F-DCA98C7E8130Q35212984-2B84F1FF-425A-4710-BF8F-13FE02BDC472Q35220262-2BBEA461-0018-4796-851B-F60AE7CF01B6Q35222697-9100362C-C4CE-4C5B-8F85-04455531EAF0Q35237718-83DE681A-66D9-4204-86F7-6B00158C15D4Q35505900-FE7D78EE-D2AB-422E-B472-1D5E4FD1380FQ35545020-514CD7F0-D012-46F3-BBD6-FBCAAD7C4FAA
P2860
Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations
description
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1998
@ast
im Mai 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1998/05/01)
@sk
vědecký článek publikovaný v roce 1998
@cs
wetenschappelijk artikel (gepubliceerd op 1998/05/01)
@nl
наукова стаття, опублікована в травні 1998
@uk
مقالة علمية (نشرت في مايو 1998)
@ar
name
Locomotor activity in D2 dopam ...... and developmental adaptations
@ast
Locomotor activity in D2 dopam ...... and developmental adaptations
@en
Locomotor activity in D2 dopam ...... and developmental adaptations
@nl
type
label
Locomotor activity in D2 dopam ...... and developmental adaptations
@ast
Locomotor activity in D2 dopam ...... and developmental adaptations
@en
Locomotor activity in D2 dopam ...... and developmental adaptations
@nl
prefLabel
Locomotor activity in D2 dopam ...... and developmental adaptations
@ast
Locomotor activity in D2 dopam ...... and developmental adaptations
@en
Locomotor activity in D2 dopam ...... and developmental adaptations
@nl
P2093
P3181
P1476
Locomotor activity in D2 dopam ...... and developmental adaptations
@en
P2093
C N Lessov
D K Grandy
G A Gerhardt
J R Bunzow
M Rubinstein
S Burkhart-Kasch
T J Phillips
P304
P3181
P356
10.1523/JNEUROSCI.18-09-03470.1998
P407
P577
1998-05-01T00:00:00Z